
Entia Biosciences, Inc. – OTC:ERGO
Entia Biosciences stock price today
Entia Biosciences stock price monthly change
Entia Biosciences stock price quarterly change
Entia Biosciences stock price yearly change
Entia Biosciences key metrics
Market Cap | 235.62K |
Enterprise value | 978.39K |
P/E | N/A |
EV/Sales | 3.68 |
EV/EBITDA | -0.75 |
Price/Sales | 0.03 |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.05 |
Revenue | 265.46K |
EBITDA | -1.15M |
Income | -1.47M |
Revenue Q/Q | -32.76% |
Revenue Y/Y | -23.47% |
Profit margin | -525.78% |
Oper. margin | -493.6% |
Gross margin | 65.53% |
EBIT margin | -493.6% |
EBITDA margin | -435.58% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEntia Biosciences stock price history
Entia Biosciences stock forecast
Entia Biosciences financial statements
Mar 2016 | 79.2K | -279.98K | -353.52% |
---|---|---|---|
Jun 2016 | 98.42K | -419.51K | -426.23% |
Sep 2016 | 41.85K | -303.41K | -724.91% |
Dec 2016 | 45.98K | -469.74K | -1021.49% |
Mar 2016 | 405772 | 1.43M | 353.01% |
---|---|---|---|
Jun 2016 | 399798 | 1.78M | 447.69% |
Sep 2016 | 365827 | 2.00M | 549.26% |
Dec 2016 | 439141 | 2.40M | 547.82% |
Mar 2016 | -99.19K | -4.52K | 79.58K |
---|---|---|---|
Jun 2016 | -102.33K | -2.58K | 122.68K |
Sep 2016 | -73.61K | 0 | 57.87K |
Dec 2016 | -439.95K | 0 | 513.98K |
Entia Biosciences alternative data
Aug 2023 | 6 |
---|---|
Sep 2023 | 6 |
Oct 2023 | 6 |
Nov 2023 | 6 |
Dec 2023 | 6 |
Jan 2024 | 6 |
Feb 2024 | 6 |
Mar 2024 | 6 |
Apr 2024 | 6 |
May 2024 | 6 |
Jun 2024 | 6 |
Jul 2024 | 6 |
Entia Biosciences other data
-
What's the price of Entia Biosciences stock today?
One share of Entia Biosciences stock can currently be purchased for approximately $0.
-
When is Entia Biosciences's next earnings date?
Unfortunately, Entia Biosciences's (ERGO) next earnings date is currently unknown.
-
Does Entia Biosciences pay dividends?
No, Entia Biosciences does not pay dividends.
-
How much money does Entia Biosciences make?
Entia Biosciences has a market capitalization of 235.62K.
-
What is Entia Biosciences's stock symbol?
Entia Biosciences, Inc. is traded on the OTC under the ticker symbol "ERGO".
-
What is Entia Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Entia Biosciences?
Shares of Entia Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Entia Biosciences have?
As Jul 2024, Entia Biosciences employs 6 workers.
-
When Entia Biosciences went public?
Entia Biosciences, Inc. is publicly traded company for more then 11 years since IPO on 15 Jul 2014.
-
What is Entia Biosciences's official website?
The official website for Entia Biosciences is entiabio.com.
-
Where are Entia Biosciences's headquarters?
Entia Biosciences is headquartered at 13565 SW Tualatin-Sherwood Road, Sherwood, OR.
-
How can i contact Entia Biosciences?
Entia Biosciences's mailing address is 13565 SW Tualatin-Sherwood Road, Sherwood, OR and company can be reached via phone at +971 2280709.
Entia Biosciences company profile:

Entia Biosciences, Inc.
entiabio.comOTC
6
Biotechnology
Healthcare
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Sherwood, OR 97140
:
ISIN: US29384E1047
CUSIP: 29384E104